ATMAN 3.0 Accelerator at IIT-B Supports Early-Stage HealthTech Innovators
The Technology Innovation Hub (TIH) for Translational Research in IoT and IoE at IIT Bombay has launched the third edition of its HealthTech accelerator, ATMAN 3.0. This initiative aims to support early-stage ventures in the health technology sector by providing them with a structured platform for growth and development.
Overview of ATMAN 3.0
ATMAN 3.0 is designed as an intensive, eight-week program that focuses on transforming innovative ideas into investment-ready businesses. The program has attracted 13 early-stage ventures selected from a pool of 173 applicants who pitched their ideas to TIH experts during the preliminary screening process.
Program Structure
The ATMAN 3.0 program is structured to enhance the essential competencies required for HealthTech startups to progress from the prototype stage to early commercialization. Founders are guided through key areas including:
- Product refinement
- Regulatory preparedness
- Market understanding
- Business modeling
- Fundraising readiness
Curriculum Modules
The curriculum is organized into eight modules that integrate:
- Clinical insights
- Technological validation
- Commercial strategy
Throughout the eight weeks, selected startups will work closely with clinicians, domain specialists, and business mentors. This collaboration aims to assess real-world needs, address usability and safety requirements, and align innovations with the regulatory standards governing medical technology.
Innovative Ventures in the Cohort
The cohort includes a diverse range of ventures focused on developing solutions across various sectors of health technology. These include:
- Medical devices
- Digital therapeutics
- Rehabilitation technologies
- Diagnostic platforms
- Remote patient monitoring
Some notable innovations from the participating startups include:
- Needle-tracking devices
- Antimicrobial resistance testing tools
- Stroke-rehabilitation systems
- Digital gut-health therapeutics
- Senior-care wearables
- Portable vital-monitoring platforms
Support and Evaluation
Each team will receive ongoing evaluation to help refine their prototypes, validate clinical applications, and ensure feasibility for large-scale deployment. This supportive environment is crucial for startups as they navigate the complexities of the health technology landscape.
Demo Day and Funding Opportunities
The program will culminate in a Demo Day scheduled for January 9, 2026, at Novotel Mumbai International Airport. During this event, startups will have the opportunity to pitch their innovations to investors, healthcare leaders, and members of TIH’s investment committee.
Participating ventures will be evaluated for funding support of Rs 1 crore or more, which is aimed at helping them advance through subsequent stages of product development and regulatory navigation. The Demo Day will also feature discussions on:
- Emerging healthcare technologies
- Regulatory pathways
- Investment trends
Previous portfolio startups from TIH IIT Bombay will also participate in the event, fostering follow-on funding discussions and potential partnerships within the HealthTech community.
Conclusion
As India accelerates its efforts toward innovation-led development, ATMAN 3.0 serves as a vital platform for early-stage healthtech entrepreneurs. By converting research ideas into viable healthcare solutions, the program continues to strengthen the pipeline of student and early-career innovators entering India’s HealthTech ecosystem.
Note: The information provided in this article is based on the latest updates from IIT Bombay and the ATMAN 3.0 program as of December 2025.
